Marquette Asset Management LLC raised its stake in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 89.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 47,166 shares of the company’s stock after purchasing an additional 22,301 shares during the period. Marquette […]
Stonepine Capital Management LLC boosted its stake in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 9.9% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 752,088 shares of the company’s stock after purchasing an additional 67,580 shares during […]
Auour Investments LLC bought a new position in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 177,000 shares of the company’s stock, valued at approximately $662,000. Auour Investments LLC owned about 0.21% of […]
Sectoral Asset Management Inc. purchased a new stake in shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 281,403 shares of the company’s stock, valued at approximately $1,354,000. Sectoral Asset Management […]
Sectoral Asset Management Inc. bought a new position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 281,403 shares of the company’s stock, valued at approximately $1,354,000. Several other institutional investors and hedge […]